PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTestosterone
Testoderm, Livensa(testosterone)
Androgel, Azmiro, Depo-testadiol, Ditate, Intrinsa, Livensa, Natesto, Testim, Testopel, Testosterone, Vogelxo, Xyosted (testosterone) is a small molecule pharmaceutical. Testosterone was first approved as Depo-testadiol on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, and hypogonadism in the USA. It has been approved in Europe to treat psychological sexual dysfunctions. The pharmaceutical is active against androgen receptor.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
mental disordersD001523
Trade Name
FDA
EMA
Azmiro, Depo-testosterone, Natesto, Testim, Testopel, Testosterone, Testosterone cypionate, Vogelxo (discontinued: Androderm, Axiron, Depo-testosterone, Fortesta, Striant, Testoderm, Testosterone, Testosterone cypionate)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Testosterone
Tradename
Company
Number
Date
Products
NATESTOAcerus Pharmaceuticals CorporationN-205488 RX2014-05-28
1 products, RLD, RS
TESTIMEndoN-021454 RX2002-10-31
1 products, RLD, RS
VOGELXOUpsher-Smith LaboratoriesN-204399 RX2014-06-04
2 products
Show 8 discontinued
Estradiol cypionate
+
Testosterone cypionate
Tradename
Company
Number
Date
Products
DEPO-TESTADIOLPharmacia & UpjohnN-017968 DISCN1982-01-01
1 products
Hide discontinued
Testosterone cypionate
Tradename
Company
Number
Date
Products
AZMIROAzurityN-216318 RX2022-06-02
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
androgelNew Drug Application2024-09-18
aveedNew Drug Application2021-08-28
axironNew Drug Application2013-11-12
azmiroNew Drug Application2025-01-03
depo-testosteroneANDA2024-01-11
jatenzoNew Drug Application2025-05-16
kyzatrexNew Drug Application2023-10-26
natestoNew Drug Application2025-03-31
striantNew Drug Application2009-11-19
testimNew Drug Application2021-08-25
Show 12 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
breast neoplasmsEFO_0003869D001943C50
hypogonadism—D007006E23.0
delayed puberty—D011628E30.0
prostatic neoplasms—D011471C61
menorrhagiaEFO_0003945D008595N92.0
primary ovarian insufficiencyEFO_0004266D016649E28.3
hot flashes—D019584—
premature menopause—D008594E28.31
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Testosterone Cypionate, Testosterone Cypionate, Slayback Pharma Llc
113115542039-03-25DP
116423552039-03-25DP
Testosterone Enanthate, Xyosted (Autoinjector), Antares Pharma Inc
106464952038-08-30DP
99501252036-09-04DPU-2418
97443022035-11-19DP
111919082035-10-18DP
118134352035-02-25DP
102386622035-02-19DPU-2418
109127822035-02-19DPU-2418
111607512034-10-07DPU-2418
108817982034-02-11DP
108210722033-06-04DPU-2418
118448042033-06-04U-2418
103576092031-08-21DP
109058272031-08-21DP
114464402031-08-21DP
102791312031-07-31DP
114977532030-03-19DP
80213352026-10-04DP
85625642026-01-24DP
91802592026-01-24DP
95331022026-01-24DP
96299592026-01-24DP
104785602026-01-24DP
114464412026-01-24DP
Testosterone, Natesto, Acerus
110903122034-03-17U-1616
85746222024-02-04DP
87848692024-02-04DP
87848822024-02-04DPU-1557
88772302024-02-04U-1616
Testosterone, Vogelxo, Upsher Smith Labs
87854262034-02-11DPU-1531
92956752034-02-11DPU-1531
96623402034-02-11DPU-1531
Testosterone, Axiron, Eli Lilly And Co
84359442027-09-27U-1390
84193072027-02-26U-1386
88078612027-02-26DPU-1563
92895862027-02-26U-1390
89935202026-06-02U-1390
91801942026-06-02U-1390
Testosterone, Androgel, Besins Hlthcare
84661362026-10-12DP
84661372026-10-12U-1103
84661382026-10-12U-1103
84869252026-10-12DP
87290572026-10-12DP
87418812026-10-12U-1103
87540702026-10-12DP
87593292026-10-12DP
ATC Codes
G: Genito urinary system and sex hormones
— G03: Sex hormones and modulators of the genital system
— G03B: Androgens
— G03BA: 3-oxoandrosten (4) derivatives
— G03BA03: Testosterone
— G03E: Androgens and female sex hormones in combination
— G03EA: Androgens and estrogens
— G03EA02: Testosterone and estrogen
— G04: Urologicals
— G04C: Drugs used in benign prostatic hypertrophy
— G04CB: Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy
HCPCS
Code
Description
J1071
Injection, testosterone cypionate, 1 mg
J3121
Injection, testosterone enanthate, 1 mg
J3145
Injection, testosterone undecanoate, 1 mg
S0189
Testosterone pellet, 75 mg
Clinical
Clinical Trials
891 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypogonadismD007006—E23.03368555449250
Prostatic neoplasmsD011471—C61167227627141
EunuchismD005058EFO_0007266E29.161112111250
SyndromeD013577——65452040
Healthy volunteers/patients———13723528
ObesityD009765EFO_0001073E66.934351327
InfertilityD007246EFO_0000545—73711127
Polycystic ovary syndromeD011085EFO_0000660E28.264111527
Erectile dysfunctionD007172EFO_0004234F52.212227821
Psychological sexual dysfunctionsD020018—F52.015121221
Show 87 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Castration-resistant prostatic neoplasmsD064129——3131—118
AdenocarcinomaD000230——2123——17
NeoplasmsD009369—C80153—413
CarcinomaD002277—C80.0381——12
Male infertilityD007248EFO_0004248N46224—512
Breast neoplasmsD001943EFO_0003869C50341—411
Spinal cord injuriesD013119EFO_1001919—272—19
Neoplasm metastasisD009362EFO_0009708——34——7
Delayed pubertyD011628—E30.0—11—56
FatigueD005221—R53.83—41—16
Show 40 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ContraceptionD003267——86——112
HypersensitivityD006967EFO_0003785T78.4023——38
Gonadal disordersD006058——14——48
Endocrine system diseasesD004700EFO_0001379E34.923——48
HyperandrogenismD017588———2——68
Androgen-insensitivity syndromeD013734—E34.513——58
Gender identityD005783——11——56
Primary ovarian insufficiencyD016649EFO_0004266E28.312——35
Premature menopauseD008594—E28.3112——35
Kidney diseasesD007674EFO_0003086N08—1——45
Show 68 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I102———35
Muscular dystrophiesD009136EFO_0000757G71.01———23
Sleep deprivationD012892—F51.122————2
HivD006678—O98.71———12
Male breast neoplasmsD018567——1———12
Antibiotic prophylaxisD019072——1————1
Facioscapulohumeral muscular dystrophyD020391EFO_0000491G71.021————1
Cerebral arterial diseasesD002539EFO_1000859—1————1
PharmacokineticsD010599——1————1
Bone diseasesD001847—M89.91————1
Show 15 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pituitary diseasesD010900—E23.7————66
Acne vulgarisD000152EFO_0003894L70————44
Blood pressureD001794EFO_0004325—————33
Anxiety disordersD001008EFO_0006788F41.1————33
Hormone replacement therapyD020249EFO_0003961Z79.890————33
EndometriosisD004715EFO_0001065N80————33
Hematologic diseasesD006402EFO_0005803D75.9————22
Beta-thalassemiaD017086Orphanet_848D56.1————22
ThalassemiaD013789EFO_1001996D56————22
HemorrhageD006470MP_0001914R58————22
Show 136 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTestosterone
INNtestosterone
Description
Testosterone is an androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.. It has a role as an androgen, a human metabolite, a Daphnia magna metabolite and a mouse metabolite. It is a 17beta-hydroxy steroid, an androstanoid, a C19-steroid and a 3-oxo-Delta(4) steroid.
Classification
Small molecule
Drug classsteroids (androgens, anabolics); antiandrogens
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O
Identifiers
PDB—
CAS-ID58-22-0
RxCUI—
ChEMBL IDCHEMBL386630
ChEBI ID17347
PubChem CID6013
DrugBankDB00624
UNII ID3XMK78S47O (ChemIDplus, GSRS)
Target
Agency Approved
AR
AR
Organism
Homo sapiens
Gene name
AR
Gene synonyms
DHTR, NR3C4
NCBI Gene ID
367
Protein name
androgen receptor
Protein synonyms
Dihydrotestosterone receptor, Nuclear receptor subfamily 3 group C member 4
Uniprot ID
Q9UD95
Mouse ortholog
Ar (11835)
androgen receptor (P19091)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Striant – Juniper Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Androgel – AbbVie
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Testim – Auxilium Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Testopel – Auxilium Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Testosterone
+
Estradiol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Testosterone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 36,249 documents
View more details
Safety
Black-box Warning
Black-box warning for: Androgel, Aveed, Axiron, Kyzatrex, Testim, Testosterone, Testosterone gel, 1%, Tlando, Undecatrex, Vogelxo
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
33,481 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use